Positions
- Professor
-
Pathology
Baylor College of Medicine
Houston, TX, US
- William D. Tigertt Chair in Pathology
-
Baylor College of Medicine
Houston, Texas, United States
- Co-Leader, Cancer Biology Program
-
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States
- Director, Human Tissue Acquisition & Pathology Shared Resource
-
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas, United States
Addresses
- BCM-Ben Taub Research Center (Lab)
-
Room: BCMT-T221
Houston, TX, 77030
United States
- BCM-Ben Taub Research Center (Office)
-
Room: BCMT-T221
Houston, TX, 77030
United States
Education
- B.S. from Michigan State University
- 01/1976 - East Lansing, MI, United States
- Ph.D. from Case Western Reserve University
- 01/1982 - Cleveland, OH, United States
- Advanced Training from New York University Medical Center
- 01/1984 - New York, NY, United States
- M.D. from Case Western Reserve University
- 01/1983 - Cleveland, OH, United States
- Advanced Training from New York University
- 01/1987 - New York, NY, United States
- Advanced Training from New York University Medical Center
- 01/1985 - New York, NY, United States
Certifications
- Physician
- #K6016 (02/28/2020 - 02/28/2022)
- Texas Medical Board
Professional Interests
- Molecular genetics of prostate cancer
- Fibroblast growth factors
- Benign Prostatic Hyperplasia
Websites
Selected Publications
-
Yang F, Zhang Y, Ressler SJ, Ittmann MM, Ayala GE, Dang TD, Wang F, Rowley DR. " FGFR1 is Essential for Prostate Cancer Progression and Metastasis. " Cancer Res.. 2013 Apr 10;
Pubmed PMID: 23576558. -
Feng S, Dakhova O, Creighton CJ, Ittmann M. " Endocrine Fibroblast Growth Factor FGF19 Promotes Prostate Cancer Progression. " Cancer Res.. 2013 Apr 15; 73 (8) : 2551-62.
Pubmed PMID: 23440425. -
Qin J, Wu SP, Creighton CJ, Dai F, Xie X, Cheng CM, Frolov A, Ayala G, Lin X, Feng XH, Ittmann MM, Tsai SJ, Tsai MJ, Tsai SY. " COUP-TFII inhibits TGF-ß-induced growth barrier to promote prostate tumorigenesis. " Nature. 2013 Jan 10; 493 (7431) : 236-40.
Pubmed PMID: 23201680. -
Shao L, Tekedereli I, Wang J, Yuca E, Tsang S, Sood A, Lopez-Berestein G, Ozpolat B, Ittmann M. " Highly Specific Targeting of the TMPRSS2/ERG Fusion Gene Using Liposomal Nanovectors. " Clin. Cancer Res.. 2012 Dec 15; 18 (24) : 6648-57.
Pubmed PMID: 23052253.
Funding
-
Enhancing outcomes of radiation therapy for prostate cancer
- $982,000.00 (10/01/2018 - 09/30/2021)
- Grant funding from DOD Prostate Cancer Program
- The goal of this proposal is to examine the impact of inhibition of RET and/or FGFR kinases on radiation therapy in prostate cancer
-
Tumor microenvironment-based biomarkers in African American prostate cancer
#PC170374 - $471,000.00 (10/01/2018 - 09/30/2021)
- Grant funding from DOD Prostate Cancer Program
- The goal of this proposal is to evaluate reactive stroma biomarkers in African American prostate cancer.
-
A Novel Oncogenic Axis in African American Prostate Cancer
- $500,000.00 (04/01/2019 - 03/31/2023)
- Grant funding from Dept of Veterans Affairs
- The goal of this project is to characterize the role of RGS12 in African American prostate cancer.
Log In to edit your profile